aTyr Pharma reported $7.84K in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
aTyr Pharma USD 7.84K 3.09K Sep/2025
Biogen USD 37.9M 700K Mar/2026
Compugen USD 954K 116K Sep/2025
CSL USD 18M 1000K Dec/2024
Curis USD 806K 9K Sep/2023
GlaxoSmithKline GBP 22M 96M Mar/2026
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
United Therapeutics USD 43.2M 3.2M Dec/2025